104.94 USD
▲-3.40+10.54%
盘后 94.20 -0.77%
2026-08-03
市值
$9.23B
市盈率
—
EPS
-2.17
股息率
—
52 周区间
14.51 – 105.09
成交量
831.89K
Beta
3.02
目标价
105.79
52W 低 14.5152W 高 105.09
价格走势
公司简介
Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD) and rheumatic diseases. The company develops SPY001, a humanized monoclonal immunoglobulin G1 antibody that is in phase-2 clinical stage designed to bind selectively to the α4β7 integrin being developed for the treatment of IBD (ulcerative colitis and Crohn’s disease); and SPY002 and SPY072 – anti-TL1A mAbs designed to bind to tumor necrosis factor-like ligand 1A (TL1A). It is also develo...